Sugi Predict

Sugi Predict / Compounds / SCHEMBL1670982

SCHEMBL1670982

SCHEMBL1670982

O=C(O)c1sccc1-c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BCAT2 O15382 1/20 0.72
▸ RXFP1 Q9HBX9 2/20 0.50
▸ DHODH Q02127 1/20 0.50
▸ RORB Q92753 4/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ KMT2A Q03164 2/20 0.47
▸ PTPRC P08575 1/20 0.46
▸ FABP4 P15090 1/20 0.45
▸ FABP5 Q01469 1/20 0.45
▸ GABRA1 P14867 1/20 0.44
▸ GABRG2 P18507 1/20 0.44
▸ GABRB3 P28472 1/20 0.44
▸ GABRA5 P31644 1/20 0.44
▸ GABRA3 P34903 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ GPR35 Q9HC97 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9121778 0.88 BCAT2 (0.72) BCAT2RXFP1RORBALDH1A1TSHR
SCHEMBL4445671 0.84 BCAT2 (1.00) BCAT2RXFP1RORBALDH1A1TSHR
SCHEMBL2980845 0.84 BCAT2 (0.68) BCAT2RXFP1RORBALDH1A1TSHR
SCHEMBL9394563 0.82 BCAT2 (0.66) BCAT2RXFP1RORBALDH1A1TSHR
SCHEMBL1340183 0.82 BCAT2 (0.51) BCAT2
SCHEMBL6664795 0.82 BCAT2 (0.51) BCAT2RXFP1DHODHRORBNPSR1
SCHEMBL6200929 0.82 BCAT2 (0.51) BCAT2RORBALDH1A1GPR35
Hydrochloric Acid SCHEMBL31228833 0.82 BCAT2 (0.96) BCAT2RXFP1RORBALDH1A1TSHR
SCHEMBL27749147 0.82 BCAT2 (0.51) BCAT2RORBALDH1A1TSHRKMT2A
SCHEMBL1339762 0.82 BCAT2 (0.51) BCAT2RXFP1DHODHRORBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828177-A2 NOVEL MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2007-09-05 — — EP claimed
US-7109243-B2 Inhibitors of cathepsin S IRM LLC (BM) 2006-09-19 — — US claimed
WO-2006066173-A2 NOVEL MCH RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2006-06-22 — — WO claimed
US-12378254-B2 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2025-08-05 — — US disclosed
CN-119192103-A Five-membered heterocyclic amide compound, preparation method and application thereof, and bactericide 贵州大学 2024-12-27 — — CN disclosed
US-20240109901-A1 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-C]PYRROLES AS OREXIN RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-04-04 — — US disclosed
US-11667644-B2 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2023-06-06 — — US disclosed
WO-2023074408-A1 THIOPHENE COMPOUND, METHOD FOR SYNTHESIZING SAME, AND COMPOSITION CONTAINING SAID THIOPHENE COMPOUND 四国化成工業株式会社 2023-05-04 — — WO disclosed
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 — — US disclosed
CN-107849035-B Phenyl heterocyclic derivative and application thereof in medicine 四川海思科制药有限公司 2021-12-10 — — CN disclosed
US-RE48841-E1 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2021-12-07 — — US disclosed
WO-2005070916-A1 THIOPHENE AND FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 2005-08-04 — — WO disclosed
US-20050014765-A1 Aryl-heteroaromatic products, compositions comprising them and use AVENTIS PHARMA S.A. (FR) 2005-01-20 — — US disclosed
WO-2004084842-A2 INHIBITORS OF CATHEPSIN S IRM LLC (BM) 2004-10-07 — — WO disclosed
EP-1464646-A1 Thieno(2,3-C) Isoquinolines for use as inhibitors of Parp SMITHKLINE BEECHAM PLC (GB) 2004-10-06 — — EP disclosed
US-20040082789-A1 Thieno[2,3-c]iosquinolines for use as inhibitors of parp MORONI, FLAVIO (IT) 2004-04-29 — — US disclosed
EP-1332147-A1 THIENO[2,3-C ISOQUINOLINES FOR USE AS INHIBITORS OF PARP SMITHKLINE BEECHAM PLC (GB) 2003-08-06 — — EP disclosed
WO-2002036599-A1 THIENO[2,3-C]ISOQUINOLINES FOR USE AS INHIBITORS OF PARP SMITHKLINE BEECHAM P.L.C. (GB) 2002-05-10 — — WO disclosed
US-4571437-A CATALYTIC HYDROGENATION REDUCTION AND REARRANGEMENT OF NITROBENZENE IN PRESENCE OF SULFUR COMPOUND MALLINCKRODT, INC. (US) 1986-02-18 — — US disclosed
US-4093622-A Pyridine esters of cyclopropane-carboxylic acid ZOECON CORPORATION (US) 1978-06-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014765-A1 Aryl-heteroaromatic products, compositions comprising them and use AHR, ARNT, MYC BCAT2 1711/4885RXFP1 4841/4885DHODH 1510/4885
US-20240109901-A1 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-C]PYRROLES AS OREXIN RECEPTOR MODULATORS HCRTR2, HCRTR1, OXTR BCAT2 4211/4885RXFP1 140/4885DHODH 648/4885
US-12378254-B2 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators HCRTR2, HCRTR1, OXTR BCAT2 4211/4885RXFP1 140/4885DHODH 648/4885
US-20040082789-A1 Thieno[2,3-c]iosquinolines for use as inhibitors of parp PARP1, PARP2, PARP12 BCAT2 2987/4885RXFP1 3576/4885DHODH 749/4885
US-11667644-B2 Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators HCRTR2, HCRTR1, OXTR BCAT2 4211/4885RXFP1 140/4885DHODH 648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.